Journal Article Interleukin 3: Biological and clinical effects Get access Wolfgang Oster, M.D., Wolfgang Oster, M.D. Behringwerke AG, Marburg, Federal Republic of Germany Correspondence: Wolfgang Oster, M.D., Behringwerke AG, Clinical Research Immunology/Oncology, P.O. Box 11 40, 3550 Marburg, FRG. Search for other works by this author on: Oxford Academic Google Scholar Gregor Schulz Gregor Schulz Behringwerke AG, Marburg, Federal Republic of Germany Search for other works by this author on: Oxford Academic Google Scholar The International Journal Of Cell Cloning, Volume 9, Issue 1, 1991, Pages 5–23, https://doi.org/10.1002/stem.5530090105 Published: 01 January 1996 Article history Received: 15 November 1990 Accepted: 15 November 1990 Published: 01 January 1996
No takes yet. Share an insight, caveat, or question.
Oster et al. (1991) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: